Aquestive Therapeutics (AQST) stock, explained like you're 5

Is Aquestive Therapeutics a small, medium or large cap company?

No. Aquestive Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 600 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Aquestive Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves AQST stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Aquestive Therapeutics, Inc. (AQST) Stock Price, News, Quote & History (Yahoo! Finance Canada)
• Aquestive Therapeutics Stock Price Forecast. Should You Buy AQST? (StockInvest.us)
• CEO sells 25,000 shares under a trading plan at Aquestive (AQST). (Stock Titan)
• $AQST stock is down 11% today. Here's what we see in our data. (Quiver Quantitative)
• Aquestive: FDA Acceptance Of Anaphylm Resubmission Makes For Rating Upgrade (NASDAQ:AQST) (Seeking Alpha)

Key terms to know before you follow AQST

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility